Envestnet Asset Management’s Allogene Therapeutics ALLO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $21.5K | Sell |
19,026
-269
| -1% | -$304 | ﹤0.01% | 4409 |
|
|
2025
Q1 | $28.2K | Sell |
19,295
-1,794
| -9% | -$2.62K | ﹤0.01% | 4322 |
|
|
2024
Q4 | $44.9K | Buy |
21,089
+5,490
| +35% | +$11.7K | ﹤0.01% | 4267 |
|
|
2024
Q3 | $43.7K | Buy |
15,599
+1,638
| +12% | +$4.59K | ﹤0.01% | 4184 |
|
|
2024
Q2 | $32.5K | Buy |
13,961
+1,634
| +13% | +$3.81K | ﹤0.01% | 4127 |
|
|
2024
Q1 | $55.1K | Buy |
+12,327
| New | +$55.1K | ﹤0.01% | 4101 |
|
|
2021
Q4 | – | Sell |
-15,191
| Closed | -$390K | – | 3867 |
|
|
2021
Q3 | $390K | Sell |
15,191
-62
| -0.4% | -$1.59K | ﹤0.01% | 3126 |
|
|
2021
Q2 | $398K | Buy |
15,253
+65
| +0.4% | +$1.7K | ﹤0.01% | 3112 |
|
|
2021
Q1 | $536K | Buy |
+15,188
| New | +$536K | ﹤0.01% | 2803 |
|